- Tytuł:
- Primary systemic therapy in HER2-positive operable breast cancer using trastuzumab and chemotherapy: efficacy data, cardiotoxicity and long-term follow-up in 142 patients diagnosed from 2005 to 2016 at a single institution
- Autorzy:
- Temat:
-
Neoadjuvant therapy
HER2-positive breast cancer
pathologic complete response
cardiotoxicity
survival
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282 - Źródło:
- Breast Cancer: Targets and Therapy, Vol Volume 11, Pp 29-42 (2018)
- Opis pliku:
- electronic resource
- Relacje:
- https://www.dovepress.com/primary-systemic-therapy-in-her2-positive-operable-breast-cancer-using-peer-reviewed-article-BCTT; https://doaj.org/toc/1179-1314
- Dostęp URL:
- https://doaj.org/article/baccee9a46d042eca38ea148ccbfb013  Link otwiera się w nowym oknie
Czasopismo naukowe